Ritonavir Recruiting Phase 2 Trials for Novel Coronavirus Infectious Disease (COVID-19) / COVID-19 Pneumonia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04321993Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
NCT04372628Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19
NCT04330690Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial
NCT04346147Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19